Company Filing History:
Years Active: 2003
Title: Kerry-Anne Rye: Innovator in Therapeutic Screening Methods
Introduction
Kerry-Anne Rye is a notable inventor based in South Australia, AU. She has made significant contributions to the field of therapeutic screening, particularly in relation to coronary heart disease and inflammatory conditions. Her innovative approach has the potential to impact the medical community positively.
Latest Patents
Kerry-Anne Rye holds a patent for a screening method that identifies therapeutic candidates affecting the sphingosine kinase signaling pathway. This method is crucial for testing the presence or absence of effects by potential therapeutic agents on components of this signaling pathway. The patent is titled "Screening method for an agent having an effect on a sphingosine kinase signaling pathway" and represents a significant advancement in therapeutic research.
Career Highlights
Kerry-Anne Rye is associated with Medvet Science Pty Ltd, where she applies her expertise in developing innovative screening methods. Her work is instrumental in advancing therapeutic options for patients suffering from coronary heart disease and related inflammatory conditions.
Collaborations
Kerry-Anne collaborates with esteemed colleagues, including Jennifer Ruth Gamble and Mathew A Vadas. These partnerships enhance her research and contribute to the development of effective therapeutic solutions.
Conclusion
Kerry-Anne Rye's contributions to the field of therapeutic screening exemplify her dedication to medical innovation. Her work not only advances scientific understanding but also holds promise for improving patient outcomes in critical health areas.